Series C funding round for EpimAb Biotherapeutics raising $120M in March 2021
Series C funding round for EpimAb Biotherapeutics raising $120M in March 2021
| Investor | Firm Type | Partner |
|---|
Mirae AssetLEAD | Private Equity | — |
| Investment Bank | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private Equity | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Adrian Cheng |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$219M
Top Valuation
-
EpimAb Biotherapeutics raised $120M in a Series C round.
The round was announced on 03/01/21.
The round was led by Tony Rong, Sungwon Song.